RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
Regenerative Medical Technologies Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced that it expects to hold an investor call within the next two weeks to discuss significant positive results in connection with its upcoming Q2 2026 filing. The call - the first in the Company's history - reflects the success of RMTG's...
Read more







